Specific Systems of Treatment
by chemical changes occurring in the intercel- lular fluid that baths the nerve endings,” ac- cording to Revici.
Hemorrhages or clotting are the next phase, followed by the terminal phase, when radical alteration of the entire metabolism is affected.
According to his theory, pain in cancer is trig- gered by the metabolic changes which unbal- ance the pH of the intercellular fluid. The fur- ther the pH deviates from normal pH (either acid or alkaline), the more intense the pain.
(Revici’s theory is different than Max Gerson’s, according to which it is the accumulation of tox- ins in the system which causes the pain. Gerson must be right, since his method of removing the toxins eliminates the pain. However, Revici’s chemi- cal change in nerve endings and intercellular pH changes might well fit in nicely into the Gerson theory: The accumulation of toxins causes the chemical and pH changes, which in turn results in pain.)
Revici’s investigations disclosed that the lip- ids in the painful neoplastic (cancerous) tissue changed. He decided that some lipids in malig- nant tumors were very different than those in normal tissue.
so-called ‘cancers-in-situ’ [cancers in one place] have disappeared without any treatment.”
Revici was careful to note that his method did not always succeed. (This is understandable, con- sidering that Revici required absolutely no changes in the patient’s way of life. His only concern was the addition of certain chemicals.)
Revici spent years searching for additional chemical compounds which might eliminate can- cer totally, but success eluded him.
On August 16, 1955, Revici demonstrated his method before a group of professionals, cancer patients, and other guests. Practically every type of cancer in almost every region of the body was demonstrated to the audience. Every one of the 18 patients shown (ranging in ages from 8 to 80), had recovered sufficiently to return to full and ac- tive lives. All had been treated free of charge. In nearly every case, previous surgical or X-ray treat- ment had failed. The oldest patient had been first treated in 1942. Cancer had reappeared (on his nose) in 1955.
Revici’s patients were generally terminal. Of those who did not die in the first three months of treatment, a third survived and showed some im- provement. A few recovered completely.
Could it be possible, he thought, that by changing the lipid content of the tissue—the cancer could be eliminated?
It seemed that these abnormal lipids were responsible for the imbalance in cancer between the sterols and the fatty acids (the two funda- mental types of lipids).
Revici’s intravenous therapy used selenium, as well as calcium, copper, and oxygen, to re- balance the body’s chemistry. During the dem- onstration, Revici said that he had recently dis- covered that much more rapid recovery occurred when he added potassium to the lipid balance program.
He found that there could be two types of lipid imbalance: too much sterols and not enough fatty acids or vice versa. His approach was to introduce into the system chemicals which would return the lipids to a normal bal- ance.
When Revici did this, he found that pH changes were normalized; bleeding could be controlled; and, finally, the strange growth of cells could be controlled or arrested. Comment- ing on this, he wrote in his 1955 book, The Con- trol of Cancer with Lipids:
Possibly because Revici’s method was chemi- cal in nature, he met with little opposition for a time. It was a treatment which only a physician could administer. But the reckoning came eventu- ally. His medical license was nearly revoked in the 1980s. However, intensive lobbying in the New York State capital, led by Congressman Guy Molinari, helped him. As a result, Revici was able to retain his medical license.
Revici Therapy—Emanuel Revici, M.D., 26 East 36th Street, New York, 10016 Ph: (212) 685- 0111
“All of these changes have been observed fol- lowing adequate lipid treatment. Moreover, in many cases significant diminution in the size of tumor masses and even their complete dis- appearance have been observed. Theoretically, such objective changes in the size of malignant neoplasms can be in part accounted for on the basis of alterations in cellular lipids, the body apparently having relatively ample means of de- fending itself against noninvasive cancer cells. One indication of this is the observation that
JAMES SHERIDAN, Ph.D., 1942
Note to researchers: Sheridan’s research work should be emulated, in the hope of producing promising anti-cancer fac- tors. In connection with this, the respiration theories of other researchers (Koch, Warburg, etc.) should also be considered.
Working Summary: Several researchers have focused on interfering with the energy sources of the cancer cell. Sheridan was one of the first.
Dr. Sheridan was both an analytical chemist